ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 459

$511K Total Retail Price of All Prescriptions

Rank: 20 out of 459

448 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

22% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,945 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 413 255 1 5
HYDROCODONE-ACETAMINOPHEN 390 222 S3 2 2
OMEPRAZOLE 362 187 3 3
SIMVASTATIN 308 157 4 1
FUROSEMIDE 291 203 5 8
METFORMIN HCL 274 160 6 7
LISINOPRIL 239 152 7 4
HYDROCHLOROTHIAZIDE 221 127 8 9
POTASSIUM CHLORIDE 205 118 9 24
GABAPENTIN 202 103 10 10
AMLODIPINE BESYLATE 177 111 11 6
ATENOLOL 165 92 12 14
ATORVASTATIN CALCIUM 164 111 13 15
CITALOPRAM HBR 136 73 14 18
ENALAPRIL MALEATE 133 71 15 77
METOPROLOL TARTRATE 132 86 16 11
GLIMEPIRIDE 129 115 17 39
NEXIUM 121 61 18 16
WARFARIN SODIUM 117 72 19 17
CARVEDILOL 99 53 20 23
AZITHROMYCIN 99 59 20 25
AMITRIPTYLINE HCL 97 65 R 22 44
TRAMADOL HCL 91 66 23 13
ZOLPIDEM TARTRATE 88 55 24 19
IBUPROFEN 87 29 25 65
RANITIDINE HCL 87 43 25 29
AMOXICILLIN 85 37 27 108
PREDNISONE 82 47 28 30
CIPROFLOXACIN HCL 82 52 28 50
SYNTHROID 78 70 30 90
LOSARTAN POTASSIUM 77 47 31 22
ALLOPURINOL 77 48 31 52
ZETIA 75 61 33 62
CLOPIDOGREL 71 58 34 55
PROPRANOLOL HCL 71 31 34 129
PROAIR HFA 68 28 36 32
MELOXICAM 65 35 37 34
METFORMIN HCL ER 64 37 38 43
PRAVASTATIN SODIUM 64 28 38 12
AMLODIPINE BESYLATE-BENAZEPRIL 63 51 40 95
LANTUS SOLOSTAR 62 47 41 123
SPIRIVA 62 36 41 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 40 43 21
CEPHALEXIN 57 30 44 136
ROPINIROLE HCL 53 41 45 94
PAROXETINE HCL 53 49 45 58
DOXYCYCLINE HYCLATE 52 19 47 135
DIGOXIN 50 41 48 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.